GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bangkok Dusit Medical Services PCL BDMS.BK · THB

Health Care · SET · 🇹🇭 Thailand

Compare

20.10

+1.01%

Close of 9 Nov 2026, in THB

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Bangkok Dusit Medical Services PCL

Its shares trade on SET under the ticker BDMS.BK. It has been listed since 2 October 1991. In the fiscal year to 31 December 2025, it reported revenue of THB 111.51bn and net income of THB 15.85bn. At that date it held total assets of THB 157.96bn and shareholders' equity of THB 105.89bn.

Bangkok Dusit Medical Services Public Co. Ltd. engages in the health care businesses. The company is headquartered in Bangkok, Bangkok Metropolis. The firm and its subsidiaries operate two business segments, which consist of hospital operations and other businesses that support hospital business, including central lab services, the manufacture and distribution of medicine and pharmaceutical products, assets management for healthcare business, restaurants and distribution of health food products, facility management, technology and information services, accounting services, training business, health insurance and life insurance brokerage. Its subsidiaries comprise Samitivej PCL., Bangkok Hospital Hatyai Co., Ltd., Bangkok Phuket Hospital Co., Ltd., BNH Medical Center Co., Ltd., Bangkok Phrapradaeng Hospital Co., Ltd., Bangkok Pattaya Hospital Co., Ltd., Bangkok Rayong Hospital Co., Ltd. and Bangkok Samui Hospital Co., Ltd., among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
2 Oct 1991
Employees
33,251

Leadership

Pay as last reported

  • Prof. Santasiri SornmaniIndependent Chairman of the BoardTHB 8.9m
  • Ms. Poramaporn Prasarttong-OsothPresident, Executive Director, Chief Executive Officer - Group 1, since 2014THB 6.9m
  • Dr. Chuladej YossundharakulExecutive Vice Chairman of the BoardTHB 6.8m
  • Mrs. Narumol Noi-amChief Financial Officer, Senior Executive Vice President, Director, since 2020THB 6.8m
  • Mr. Att ThongtangChief Executive Officer- Group 5, Director, since 2016THB 5.9m
  • Mrs. Wannapa PavavechAssistant Chief Financial Officer, Acting Chief Executive Officer Group 7.2
  • Mr. Chairat PanthuraamphornChief Operating Officer, Executive Director, since 2019THB 6.6m
  • Mr. Sripop SarasasChief Administrative Officer, Director, since 2008THB 6.2m
  • Ms. Kessara WongsekateVice President, Company Secretary
  • Mr. Thongchai Jira-alongkornExecutive DirectorTHB 6.6m
  • Mr. Pradit TheekakulExecutive DirectorTHB 6.3m
  • Dr. Trin CharumilindChief Medical Officer, since 2018

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
74
Environment
99
Social
99
Governance
25
Direct emissions (scope 1)
31,975.36 t
Energy emissions (scope 2)
164,470.33 t
Value chain emissions (scope 3)
450,367.95 t
Women in the workforce
73.98027%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Bangkok Dusit Medical Services (BDMS) is one of the largest healthcare companies in Thailand, providing a wide range of medical services.
  • BDMS has a strong brand reputation and is known for its high-quality healthcare facilities and services.
  • The company has a comprehensive network of hospitals and clinics, offering accessibility to a diverse range of patients.
  • BDMS has a skilled and experienced workforce, including highly qualified doctors, specialists, and healthcare professionals.
  • The company is well-established and has a long history of successful operations, providing stability and credibility in the market.

Weaknesses

  • BDMS may face challenges in terms of rising healthcare costs and competition from other healthcare providers.
  • The company's growth may be limited by regulatory constraints and government policies on healthcare.
  • Financial risks and fluctuations in the economy can impact BDMS's revenue and profitability.
  • There may be a potential dependency on external suppliers for medical equipment and pharmaceuticals.

Opportunities

  • Thailand's growing population and increasing healthcare needs present opportunities for BDMS to expand its customer base.
  • BDMS can leverage technological advancements to improve healthcare services, such as telemedicine and electronic health records.
  • International medical tourism is a thriving industry, and BDMS can tap into this market by promoting its world-class healthcare facilities.
  • Partnerships with insurance companies and government agencies can help BDMS in securing contracts and expanding its service offerings.

Threats

  • Intensifying competition from both domestic and international healthcare providers poses a threat to BDMS's market share.
  • Changes in healthcare regulations and policies can impact BDMS's operations and financial performance.
  • Economic downturns and financial instability can lead to a decrease in consumer spending on healthcare services.
  • Negative public perception or healthcare scandals can damage BDMS's reputation and trust among patients.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.